-
-
-
-
-
-
-
Citizens JMP Reiterates Market Perform Rating on Incyte (INCY)
-
-
-
-
-
-
-
Citi Comments Incyte (INCY) New CEO
-
-
-
-
-
-
-
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
-
-
-
-
-
-
-
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
-
-
-
-
-
-
-
Incyte (INCY) Announces Acquisition of Escient Pharmaceuticals
-
-
-
-
-
-
-
Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
-
-
-
-
-
-
-
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

